同异位穴位电针对肠易激综合征腹痛影响的随机对照试验方案
本研究为随机、单盲、对照、四臂平行试验,拟纳入144例肠易激综合征患者,随机分为同位有害刺激、同位无害刺激、异位有害刺激、异位无害刺激四组,每组接受14次电针治疗(每周2次,共7周)。主要结局为视觉模拟量表疼痛强度,次要结局包括IBS症状严重度量表、生活质量问卷、痛阈及心理痛苦量表,痛阈每次治疗前后测量,其他结局在第1次治疗前、第7次和第14次治疗后及3个月随访时评估。
要点
- 采用四臂设计区分同位/异位穴位与有害/无害刺激的镇痛效应。
- 主要结局为VAS疼痛强度,次要结局涵盖症状严重度、生活质量、痛阈和心理痛苦。
- 痛阈每次治疗前后测量,其他结局在治疗前、第7次和第14次后及3个月随访评估。
核心结论
- 该研究方案旨在评估同位(腹部)与异位(下肢)穴位电针对肠易激综合征患者腹痛的镇痛效果,以及有害刺激与无害刺激之间镇痛效应的差异。
研究设计与样本
- 随机、单盲、对照、四臂平行试验,计划纳入144例肠易激综合征患者。
- 患者随机分为同位有害刺激组(A组)、同位无害刺激组(B组)、异位有害刺激组(C组)和异位无害刺激组(D组)。
- 每组接受14次治疗,每周2次,共7周。
关键数值与推荐
- 主要结局为视觉模拟量表测量的疼痛强度。
- 次要结局包括IBS症状严重度量表、IBS生活质量问卷、痛阈和症状自评量表-90心理痛苦。
- 痛阈在每次治疗前后测量;其他结局在第1次治疗前、第7次和第14次治疗后及3个月随访时评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acupuncture has been widely applied in the clinic to treat irritable bowel syndrome (IBS), but the underlying mechanism remains unknown. Diffuse noxious inhibitory control (DNIC) is deficient in patients with IBS, which attenuates the systemic analgesic effect elicited by noxious stimulation that is remote from pain areas. Therefore, the aim of this study is to investigate the analgesic effect of electroacupuncture (EA) at homotopic or heterotopic acupoints on abdominal pain in patients with IBS. METHODS/DESIGN: This study is a randomized, single-blinded, controlled, four-arm parallel trial. A total of 144 patients will be randomly assigned to four groups: a homotopic noxious stimulation group (group A), a homotopic innocuous stimulation group (group B), a heterotopic noxious stimulation group (group C), and a heterotopic innocuous stimulation group (group D). Each patient will receive 14 sessions of treatment, twice per week for 7 weeks. The primary outcome will be pain intensity measured with the visual analog scale. The secondary outcomes will include the IBS Symptom Severity Scale, IBS Quality of Life questionnaire, pain threshold (PT), and the Symptom Checklist-90 for psychological distress. The PT will be measured before and after every treatment. All other outcomes will be evaluated before the 1st treatment, after 7th and 14th treatment, and 3 months later during follow-up. DISCUSSION: The aim of this study is to assess the analgesic effect of EA at homotopic (abdomen) acupoints and heterotopic (lower limb) acupoints on abdominal pain in patients with IBS, as well as the difference in analgesic effects between noxious and innocuous stimulation. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-IPR-15006879 . Registered on 5 August 2015.
引用
- Peng Y, You H, Chen X, et al. Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30326940. doi:10.1186/s13063-018-2948-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。